Envoy Medical director files initial Form 3

Envoy Medical, Inc. director Chas McKhann filed an initial Form 3 statement of beneficial ownership for the company’s common stock.

Rhea-AI Filing Summary

Envoy Medical, Inc. director Chas McKhann filed an initial Form 3 statement of beneficial ownership for the company’s common stock. The filing shows no reported purchases, sales, derivative exercises, gifts, tax withholdings, restructurings, or other transactions, and no current derivative positions listed.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Derivative transactions: 0 transactions +2 more

5 metrics

Buy transactions 0 transactions Form 3 transaction summary buyCount

Sell transactions 0 transactions Form 3 transaction summary sellCount

Derivative transactions 0 transactions Form 3 derivativeTransactionCount

Net buy/sell shares 0 shares Form 3 netBuySellShares marked neutral

Holding entries 0 entries Form 3 holdingEntries in summary

Key Terms

Form 3, beneficial ownership, reporting person, derivative transactions

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership regulatory

"initial Form 3 statement of beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"reportingPersons: { "name": "McKhann Chas" }"

derivative transactions financial

"derivativeTransactionCount for all derivative-type records"

Derivative transactions are contracts whose value depends on the price or performance of something else—like stocks, bonds, currencies, interest rates or commodities. Think of them as insurance or bets about a future price: investors use them to protect against losses, lock in prices, or try to amplify returns, but they can also magnify losses, create cash demands and expose a firm to the risk that the other party won’t meet its obligation, so they can materially affect a company’s financial stability and volatility.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Envoy Medical (COCH) disclose in this Form 3 filing?

Envoy Medical’s Form 3 shows director Chas McKhann filing an initial statement of beneficial ownership. The summary data reports no purchases, sales, derivative exercises, gifts, or restructurings, and indicates no current derivative positions or holding entries in this snapshot.

Who is the reporting person in Envoy Medical (COCH) Form 3?

The reporting person is Chas McKhann, identified as a director of Envoy Medical, Inc. The filing does not list officer roles or 10% ownership status for him, and it reports no transactions or derivative positions in this initial ownership statement.

Are there any insider share purchases or sales in COCH Form 3?

This Form 3 shows no insider purchases or sales by director Chas McKhann. The transaction summary records zero buy and sell transactions, zero net buy or sell shares, and no derivative exercises, indicating only an initial ownership snapshot without trading activity.

Does Envoy Medical (COCH) Form 3 report any derivative securities?

The Form 3 derivative summary for director Chas McKhann is empty. It shows zero derivative transactions and no remaining derivative positions such as options or warrants, indicating no derivative holdings are reported in this initial beneficial ownership filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:31 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McKhann Chas

(Last) (First) (Middle)

4875 WHITE BEAR PARKWAY

(Street)

WHITE BEAR LAKE MINNESOTA 55110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/15/2026

3. Issuer Name and Ticker or Trading Symbol
Envoy Medical, Inc. [ COCH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Andrew Nick as Attorney-in-Fact for Chas McKhann pursuant to Power of Attorney filed herewith	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)